Charles River Laboratories International (CRL) Price/FCF Ratio: History & Chart

Charles River Laboratories International, Inc. (CRL)CRLCharles River Laboratories International, Inc.

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 1. Research Models and Services (RMS): This division is a key supplier of high-quality rodent research models, including specially bred strains of rats and mice for experimental purposes. It also offers a comprehensive array of support services to help clients effectively utilize these models in their research and for the screening of potential non-clinical drug candidates. These include providing genetically engineered models, insourcing solutions for facility management, and diagnostic services for research animals. 2. Discovery and Safety Assessment (DSA): The DSA segment plays a crucial role in advancing early-stage drug pipelines. It delivers early-phase and in vivo discovery services focused on identifying and validating new therapeutic targets, chemical compounds, and antibodies. The ultimate goal is to prepare promising non-clinical drug and therapeutic candidates for subsequent safety evaluations. Additionally, this segment provides an extensive range of safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism studies, and pharmacokinetics. 3. Manufacturing Solutions: This segment addresses critical quality control requirements by offering in vitro methods for both routine and rapid testing of the quality of sterile and non-sterile pharmaceuticals, as well as consumer products. It also serves as a vital provider of specialized biologics testing, which is often outsourced by pharmaceutical and biotechnology companies. Furthermore, the segment supplies avian vaccine services, including specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products, all essential for vaccine production. Beyond these specialized segments, Charles River also manages contract vivarium operations, providing crucial animal housing and care facilities for its biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Wilmington, MA

19,700 employees

www.criver.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Birgit Girshick

View full financials

CRL Price/FCF Ratio Metrics

PRICE/FCF RATIO

28.35

PRICE/FCF RATIO AVG TTM

16.82

PRICE/FCF RATIO AVG 3Y

22.36

PRICE/FCF RATIO AVG 5Y

28.03

PRICE/FCF RATIO AVG 10Y

25.77

PRICE/FCF RATIO AVG 15Y

21.26

PRICE/FCF RATIO AVG 20Y

22.08

CURRENT VS TTM AVG

+68.52%

CURRENT VS 3Y AVG

+26.79%

CURRENT VS 5Y AVG

+1.14%

CURRENT VS 10Y AVG

+10.03%

CURRENT VS 15Y AVG

+33.37%

CURRENT VS 20Y AVG

+28.38%

SECTOR MEDIAN · HEALTHCARE

19.73

median of 74 covered companies

CURRENT VS SECTOR MEDIAN

+43.73%

vs the sector median at left

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Charles River Laboratories International, Inc. (CRL)	$10.91B	28.35	16.82	22.36	28.03
Bio-Techne Corporation (TECH)vs ›	$11.21B	41.68	38.33	44.32	48.65
Insulet Corp. (PODD)vs ›	$11.31B	27.80	45.73	72.89	72.89
Walgreens Boots Alliance, Inc. (WBA)vs ›	$10.37B	17.86	17.13	29.64	17.62
Molina Healthcare, Inc. (MOH)vs ›	$10.31B	37.40	31.75	50.78	33.34
Baxter International Inc. (BAX)vs ›	$11.57B	16.16	32.45	30.53	29.91
Align Technology, Inc. (ALGN)vs ›	$11.96B	17.43	18.67	29.71	39.39
Universal Health Services, Inc. (UHS)vs ›	$9.75B	10.75	13.54	17.27	41.61
Henry Schein, Inc. (HSIC)vs ›	$9.74B	23.02	21.35	20.41	19.54
Revvity, Inc. (RVTY)vs ›	$12.32B	25.02	22.22	202.63	127.47

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

Charles River Laboratories International, Inc. (CRL)

$10.91B

28.35

16.82

22.36

28.03

Bio-Techne Corporation (TECH)vs ›

$11.21B

41.68

38.33

44.32

48.65

Insulet Corp. (PODD)vs ›

$11.31B

27.80

45.73

72.89

Walgreens Boots Alliance, Inc. (WBA)vs ›

$10.37B

17.86

17.13

29.64

17.62

Molina Healthcare, Inc. (MOH)vs ›

$10.31B

37.40

31.75

50.78

33.34

Baxter International Inc. (BAX)vs ›

$11.57B

16.16

32.45

30.53

29.91

Align Technology, Inc. (ALGN)vs ›

$11.96B

17.43

18.67

29.71

39.39

Universal Health Services, Inc. (UHS)vs ›

$9.75B

10.75

13.54

17.27

41.61

Henry Schein, Inc. (HSIC)vs ›

$9.74B

23.02

21.35

20.41

19.54

Revvity, Inc. (RVTY)vs ›

$12.32B

25.02

22.22

202.63

127.47

Price/FCF Ratio FAQ

What is the Price/FCF ratio for Charles River Laboratories International, Inc. (CRL)?

The Price/FCF ratio for CRL stock is 28.35.

Is Charles River Laboratories International, Inc.'s Price/FCF ratio high or low?

The Price/FCF ratio of 28.35 is in line with its 5-year average of 28.03, around the middle of its 5-year range (10.17–48.61).

What is the TTM average Price/FCF ratio for Charles River Laboratories International, Inc. (CRL)?

The TTM average Price/FCF ratio for CRL stock is 16.82.

What is the 3Y average Price/FCF ratio for Charles River Laboratories International, Inc. (CRL)?

The 3Y average Price/FCF ratio for CRL stock is 22.36.

What is the 5Y average Price/FCF ratio for Charles River Laboratories International, Inc. (CRL)?

The 5Y average Price/FCF ratio for CRL stock is 28.03.

What is the 10Y average Price/FCF ratio for Charles River Laboratories International, Inc. (CRL)?

The 10Y average Price/FCF ratio for CRL stock is 25.77.

What is the 15Y average Price/FCF ratio for Charles River Laboratories International, Inc. (CRL)?

The 15Y average Price/FCF ratio for CRL stock is 21.26.

What is the 20Y average Price/FCF ratio for Charles River Laboratories International, Inc. (CRL)?

The 20Y average Price/FCF ratio for CRL stock is 22.08.

DATE	PRICE/FCF RATIO
2026-07-24	28.35
2026-07-23	28.68
2026-07-22	27.36
2026-07-21	27.45
2026-07-20	27.48
2026-07-17	28.07
2026-07-16	28.67
2026-07-15	28.55
2026-07-14	28.92
2026-07-13	28.74
2026-07-10	29.20
2026-07-09	29.22
2026-07-08	28.02
2026-07-07	28.61
2026-07-06	28.95
2026-07-02	28.86
2026-07-01	28.66
2026-06-30	28.37
2026-06-29	28.22
2026-06-26	26.99
2026-06-25	26.61
2026-06-24	25.28
2026-06-23	23.34
2026-06-22	22.71
2026-06-18	23.14
2026-06-17	22.81
2026-06-16	23.12
2026-06-15	23.58
2026-06-12	23.46
2026-06-11	23.53
2026-06-10	23.31
2026-06-09	23.75
2026-06-08	23.32
2026-06-05	22.69
2026-06-04	23.24
2026-06-03	22.50
2026-06-02	21.87
2026-06-01	22.78
2026-05-29	22.61
2026-05-28	22.69
2026-05-27	20.58
2026-05-26	19.61
2026-05-22	20.05
2026-05-21	19.87
2026-05-20	19.52
2026-05-19	19.07
2026-05-18	18.76
2026-05-15	18.87
2026-05-14	19.91
2026-05-13	20.37
2026-05-12	21.10
2026-05-11	21.07
2026-05-08	22.22
2026-05-07	22.73
2026-05-06	17.25
2026-05-05	17.60
2026-05-04	16.36
2026-05-01	15.74
2026-04-30	15.85
2026-04-29	15.55
2026-04-28	15.83
2026-04-27	16.25
2026-04-24	16.12
2026-04-23	15.92
2026-04-22	17.54
2026-04-21	17.38
2026-04-20	17.61
2026-04-17	17.45
2026-04-16	16.80
2026-04-15	17.14
2026-04-14	17.02
2026-04-13	16.93
2026-04-10	16.67
2026-04-09	16.66
2026-04-08	16.62
2026-04-07	16.09
2026-04-06	15.97
2026-04-02	16.51
2026-04-01	16.60
2026-03-31	16.37
2026-03-30	15.16
2026-03-27	15.11
2026-03-26	15.67
2026-03-25	15.75
2026-03-24	15.11
2026-03-23	15.00
2026-03-20	14.58
2026-03-19	14.53
2026-03-18	14.91
2026-03-17	14.59
2026-03-16	14.43
2026-03-13	14.76
2026-03-12	14.49
2026-03-11	16.03
2026-03-10	15.89
2026-03-09	16.80
2026-03-06	16.56
2026-03-05	17.21
2026-03-04	17.05
2026-03-03	16.68
2026-03-02	16.95
2026-02-27	16.94
2026-02-26	16.65
2026-02-25	15.90
2026-02-24	15.76
2026-02-23	15.52
2026-02-20	16.03
2026-02-19	15.59
2026-02-18	15.00
2026-02-17	14.41
2026-02-13	14.67
2026-02-12	14.43
2026-02-11	15.09
2026-02-10	16.48
2026-02-09	16.88
2026-02-06	17.20
2026-02-05	16.70
2026-02-04	18.33
2026-02-03	18.31
2026-02-02	19.38
2026-01-30	19.14
2026-01-29	19.24
2026-01-28	19.72
2026-01-27	19.96
2026-01-26	20.21
2026-01-23	19.97
2026-01-22	20.37
2026-01-21	20.62
2026-01-20	19.84
2026-01-16	19.97
2026-01-15	20.32
2026-01-14	19.67
2026-01-13	19.91
2026-01-12	19.89
2026-01-09	20.08
2026-01-08	19.59
2026-01-07	19.71
2026-01-06	19.65
2026-01-05	18.94
2026-01-02	18.40
2025-12-31	18.14
2025-12-30	18.36
2025-12-29	18.47
2025-12-26	18.52
2025-12-24	18.47
2025-12-23	18.44
2025-12-22	18.46
2025-12-19	17.92
2025-12-18	17.62
2025-12-17	17.82
2025-12-16	17.75
2025-12-15	18.01
2025-12-12	17.55
2025-12-11	17.68
2025-12-10	17.71
2025-12-09	16.91
2025-12-08	17.01
2025-12-05	16.76
2025-12-04	16.73
2025-12-03	16.79
2025-12-02	15.89
2025-12-01	16.01
2025-11-28	16.20
2025-11-26	16.27
2025-11-25	16.19
2025-11-24	15.50
2025-11-21	15.24
2025-11-20	14.73
2025-11-19	14.69
2025-11-18	14.78
2025-11-17	14.79
2025-11-14	15.26
2025-11-13	15.38
2025-11-12	15.59
2025-11-11	15.77
2025-11-10	15.36
2025-11-07	15.28
2025-11-06	15.54
2025-11-05	15.25
2025-11-04	15.16
2025-11-03	15.25
2025-10-31	15.35
2025-10-30	15.27
2025-10-29	15.36
2025-10-28	16.02
2025-10-27	16.65
2025-10-24	16.80
2025-10-23	16.28
2025-10-22	15.94
2025-10-21	16.05
2025-10-20	15.70
2025-10-17	15.22
2025-10-16	14.91
2025-10-15	14.55
2025-10-14	14.50
2025-10-13	14.55
2025-10-10	14.24
2025-10-09	14.67
2025-10-08	14.79
2025-10-07	14.50
2025-10-06	14.91
2025-10-03	15.12
2025-10-02	14.95
2025-10-01	14.53
2025-09-30	13.34
2025-09-29	12.53
2025-09-26	12.66
2025-09-25	12.41
2025-09-24	12.74
2025-09-23	12.81
2025-09-22	13.12
2025-09-19	13.25
2025-09-18	13.38
2025-09-17	13.02
2025-09-16	12.92
2025-09-15	12.98
2025-09-12	13.03
2025-09-11	13.62
2025-09-10	13.07
2025-09-09	13.42
2025-09-08	13.81
2025-09-05	13.98
2025-09-04	13.84
2025-09-03	13.84
2025-09-02	13.75
2025-08-29	13.92
2025-08-28	13.91
2025-08-27	13.88
2025-08-26	13.96
2025-08-25	13.99
2025-08-22	13.80
2025-08-21	13.17
2025-08-20	13.60
2025-08-19	13.51
2025-08-18	13.38
2025-08-15	13.36
2025-08-14	13.28
2025-08-13	13.21
2025-08-12	13.02
2025-08-11	12.70
2025-08-08	12.68
2025-08-07	12.77
2025-08-06	12.82
2025-08-05	15.12
2025-08-04	15.16
2025-08-01	15.07
2025-07-31	15.32
2025-07-30	15.91
2025-07-29	16.11
2025-07-28	16.16
2025-07-25	15.97
2025-07-24	15.99
2025-07-23	15.16
2025-07-22	14.75
2025-07-21	13.52
2025-07-18	13.95
2025-07-17	14.15
2025-07-16	13.99
2025-07-15	13.94
2025-07-14	14.27

DATE

PRICE/FCF RATIO

2026-07-24

28.35

2026-07-23

28.68

2026-07-22

27.36

2026-07-21

27.45

2026-07-20

27.48

2026-07-17

28.07

2026-07-16

28.67

2026-07-15

28.55

2026-07-14

28.92

2026-07-13

28.74

2026-07-10

29.20

2026-07-09

29.22

2026-07-08

28.02

2026-07-07

28.61

2026-07-06

28.95

2026-07-02

28.86

2026-07-01

28.66

2026-06-30

28.37

2026-06-29

28.22

2026-06-26

26.99

2026-06-25

26.61

2026-06-24

25.28

2026-06-23

23.34

2026-06-22

22.71

2026-06-18

23.14

2026-06-17

22.81

2026-06-16

23.12

2026-06-15

23.58

2026-06-12

23.46

2026-06-11

23.53

2026-06-10

23.31

2026-06-09

23.75

2026-06-08

23.32

2026-06-05

22.69

2026-06-04

23.24

2026-06-03

22.50

2026-06-02

21.87

2026-06-01

22.78

2026-05-29

22.61

2026-05-28

22.69

2026-05-27

20.58

2026-05-26

19.61

2026-05-22

20.05

2026-05-21

19.87

2026-05-20

19.52

2026-05-19

19.07

2026-05-18

18.76

2026-05-15

18.87

2026-05-14

19.91

2026-05-13

20.37

2026-05-12

21.10

2026-05-11

21.07

2026-05-08

22.22

2026-05-07

22.73

2026-05-06

17.25

2026-05-05

17.60

2026-05-04

16.36

2026-05-01

15.74

2026-04-30

15.85

2026-04-29

15.55

2026-04-28

15.83

2026-04-27

16.25

2026-04-24

16.12

2026-04-23

15.92

2026-04-22

17.54

2026-04-21

17.38

2026-04-20

17.61

2026-04-17

17.45

2026-04-16

16.80

2026-04-15

17.14

2026-04-14

17.02

2026-04-13

16.93

2026-04-10

16.67

2026-04-09

16.66

2026-04-08

16.62

2026-04-07

16.09

2026-04-06

15.97

2026-04-02

16.51

2026-04-01

16.60

2026-03-31

16.37

2026-03-30

15.16

2026-03-27

15.11

2026-03-26

15.67

2026-03-25

15.75

2026-03-24

15.11

2026-03-23

15.00

2026-03-20

14.58

2026-03-19

14.53

2026-03-18

14.91

2026-03-17

14.59

2026-03-16

14.43

2026-03-13

14.76

2026-03-12

14.49

2026-03-11

16.03

2026-03-10

15.89

2026-03-09

16.80

2026-03-06

16.56

2026-03-05

17.21

2026-03-04

17.05

2026-03-03

16.68

2026-03-02

16.95

2026-02-27

16.94

2026-02-26

16.65

2026-02-25

15.90

2026-02-24

15.76

2026-02-23

15.52

2026-02-20

16.03

2026-02-19

15.59

2026-02-18

15.00

2026-02-17

14.41

2026-02-13

14.67

2026-02-12

14.43

2026-02-11

15.09

2026-02-10

16.48

2026-02-09

16.88

2026-02-06

17.20

2026-02-05

16.70

2026-02-04

18.33

2026-02-03

18.31

2026-02-02

19.38

2026-01-30

19.14

2026-01-29

19.24

2026-01-28

19.72

2026-01-27

19.96

2026-01-26

20.21

2026-01-23

19.97

2026-01-22

20.37

2026-01-21

20.62

2026-01-20

19.84

2026-01-16

19.97

2026-01-15

20.32

2026-01-14

19.67

2026-01-13

19.91

2026-01-12

19.89

2026-01-09

20.08

2026-01-08

19.59

2026-01-07

19.71

2026-01-06

19.65

2026-01-05

18.94

2026-01-02

18.40

2025-12-31

18.14

2025-12-30

18.36

2025-12-29

18.47

2025-12-26

18.52

2025-12-24

18.47

2025-12-23

18.44

2025-12-22

18.46

2025-12-19

17.92

2025-12-18

17.62

2025-12-17

17.82

2025-12-16

17.75

2025-12-15

18.01

2025-12-12

17.55

2025-12-11

17.68

2025-12-10

17.71

2025-12-09

16.91

2025-12-08

17.01

2025-12-05

16.76

2025-12-04

16.73

2025-12-03

16.79

2025-12-02

15.89

2025-12-01

16.01

2025-11-28

16.20

2025-11-26

16.27

2025-11-25

16.19

2025-11-24

15.50

2025-11-21

15.24

2025-11-20

14.73

2025-11-19

14.69

2025-11-18

14.78

2025-11-17

14.79

2025-11-14

15.26

2025-11-13

15.38

2025-11-12

15.59

2025-11-11

15.77

2025-11-10

15.36

2025-11-07

15.28

2025-11-06

15.54

2025-11-05

15.25

2025-11-04

15.16

2025-11-03

15.25

2025-10-31

15.35

2025-10-30

15.27

2025-10-29

15.36

2025-10-28

16.02

2025-10-27

16.65

2025-10-24

16.80

2025-10-23

16.28

2025-10-22

15.94

2025-10-21

16.05

2025-10-20

15.70

2025-10-17

15.22

2025-10-16

14.91

2025-10-15

14.55

2025-10-14

14.50

2025-10-13

14.55

2025-10-10

14.24

2025-10-09

14.67

2025-10-08

14.79

2025-10-07

14.50

2025-10-06

14.91

2025-10-03

15.12

2025-10-02

14.95

2025-10-01

14.53

2025-09-30

13.34

2025-09-29

12.53

2025-09-26

12.66

2025-09-25

12.41

2025-09-24

12.74

2025-09-23

12.81

2025-09-22

13.12

2025-09-19

13.25

2025-09-18

13.38

2025-09-17

13.02

2025-09-16

12.92

2025-09-15

12.98

2025-09-12

13.03

2025-09-11

13.62

2025-09-10

13.07

2025-09-09

13.42

2025-09-08

13.81

2025-09-05

13.98

2025-09-04

13.84

2025-09-03

13.84

2025-09-02

13.75

2025-08-29

13.92

2025-08-28

13.91

2025-08-27

13.88

2025-08-26

13.96

2025-08-25

13.99

2025-08-22

13.80

2025-08-21

13.17

2025-08-20

13.60

2025-08-19

13.51

2025-08-18

13.38

2025-08-15

13.36

2025-08-14

13.28

2025-08-13

13.21

2025-08-12

13.02

2025-08-11

12.70

2025-08-08

12.68

2025-08-07

12.77

2025-08-06

12.82

2025-08-05

15.12

2025-08-04

15.16

2025-08-01

15.07

2025-07-31

15.32

2025-07-30

15.91

2025-07-29

16.11

2025-07-28

16.16

2025-07-25

15.97

2025-07-24

15.99

2025-07-23

15.16

2025-07-22

14.75

2025-07-21

13.52

2025-07-18

13.95

2025-07-17

14.15

2025-07-16

13.99

2025-07-15

13.94

2025-07-14

14.27

Price/FCF Ratio: 28.35

CRL Price/FCF Ratio Chart

CRL Average Price/FCF Ratio Chart

CRL Current vs Average Price/FCF Ratio Chart

CRL Price/FCF Ratio Metrics

CRL Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Price/FCF Ratio FAQ

CRL Price/FCF Ratio History

Related Metrics